Patent Strategy in Pharmaceutical Industry: Are additional patents valuable?
This book investigates lifecycle management strategies used by pharmaceutical companies attempting to maximize the value of their product portfolio. Such strategies are sometimes referred to by generic drug companies as "evergreening". The analysis focuses on two of these strategies, namel...
Saved in:
Main Author: | Donghi, Monica (auth) |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Nomos Verlagsgesellschaft mbH & Co. KG
2014
|
Series: | Munich Intellectual Property Law Center - MIPLC
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Second Generation Patents in Pharmaceutical Innovation
by: Ahn, Hyewon
Published: (2014) -
Patenting Proteomics Patentability and Scope of Protection of Three-Dimensional Protein Structure Claims under German, European and US law
by: Schuster, Martina
Published: (2010) -
Patentability Requirements for Nanotechnological Inventions An Approach from the European Patent Convention Perspective
by: Cisneros, Mario
Published: (2009) -
Patents in the Food Sector A Retrospective with Special Emphasis on the TRIPs Agreement
by: Willnegger, Eva
Published: (2008) -
Patents and Public Health Legalising the Policy Thoughts in the Doha TRIPS Declaration of 14 November 2001
by: Law, Andrew
Published: (2009)